Markus Hecht

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 37

Top Topics

Locally Advanced

Squamous Cell Carcinoma

Radiation Induced

Top Venues

Journal for immunotherapy of cancer

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

This page only lists publications with an associated author ORCID identifier.

Publications

Benjamin M Freyter, Mutaz A Abd Al-Razaq, Markus Hecht, Christian Rübe, Claudia E Rübe
Studies on Human Cultured Fibroblasts and Cutaneous Squamous Cell Carcinomas Suggest That Overexpression of Histone Variant H2A.J Promotes Radioresistance and Oncogenic Transformation. Genes 15 (7) (2024)
Benjamin M Freyter, Mutaz A Abd Al-Razaq, Markus Hecht, Christian Rübe, Claudia E Rübe
Studies on Human Cultured Fibroblasts and Cutaneous Squamous Cell Carcinomas Suggest That Overexpression of Histone Variant H2A.J Promotes Radioresistance and Oncogenic Transformation. Genes 15 (7) (2024)
Benjamin M Freyter, Mutaz A Abd Al-Razaq, Markus Hecht, Christian Rübe, Claudia E Rübe
Studies on Human Cultured Fibroblasts and Cutaneous Squamous Cell Carcinomas Suggest That Overexpression of Histone Variant H2A.J Promotes Radioresistance and Oncogenic Transformation. Genes 15 (7) (2024)
Shixiang Wang, Yi Xiong, Yihao Zhang, Haitao Wang, Minjun Chen, Jianfeng Li, Peng Luo, Yung-Hung Luo, Markus Hecht, Benjamin Frey, Udo S Gaipl, Xue-Jun Li, Qi Zhao, Hu Ma, Jian-Guo Zhou
TCCIA: a comprehensive resource for exploring CircRNA in cancer immunotherapy. Journal for immunotherapy of cancer 12 (1) (2024)
Shixiang Wang, Yi Xiong, Yihao Zhang, Haitao Wang, Minjun Chen, Jianfeng Li, Peng Luo, Yung-Hung Luo, Markus Hecht, Benjamin Frey, Udo S Gaipl, Xue-Jun Li, Qi Zhao, Hu Ma, Jian-Guo Zhou
TCCIA: a comprehensive resource for exploring CircRNA in cancer immunotherapy. Journal for immunotherapy of cancer 12 (1) (2024)
Shixiang Wang, Yi Xiong, Yihao Zhang, Haitao Wang, Minjun Chen, Jianfeng Li, Peng Luo, Yung-Hung Luo, Markus Hecht, Benjamin Frey, Udo S Gaipl, Xue-Jun Li, Qi Zhao, Hu Ma, Jian-Guo Zhou
TCCIA: a comprehensive resource for exploring CircRNA in cancer immunotherapy. Journal for immunotherapy of cancer 12 (1) (2024)
Benjamin M Freyter, Mutaz A Abd Al-Razaq, Markus Hecht, Christian Rübe, Claudia E Rübe
Studies on Human Cultured Fibroblasts and Cutaneous Squamous Cell Carcinomas Suggest That Overexpression of Histone Variant H2A.J Promotes Radioresistance and Oncogenic Transformation. Genes 15 (7) (2024)
Shixiang Wang, Yi Xiong, Yihao Zhang, Haitao Wang, Minjun Chen, Jianfeng Li, Peng Luo, Yung-Hung Luo, Markus Hecht, Benjamin Frey, Udo S Gaipl, Xue-Jun Li, Qi Zhao, Hu Ma, Jian-Guo Zhou
TCCIA: a comprehensive resource for exploring CircRNA in cancer immunotherapy. Journal for immunotherapy of cancer 12 (1) (2024)
Shixiang Wang, Yi Xiong, Yihao Zhang, Haitao Wang, Minjun Chen, Jianfeng Li, Peng Luo, Yung-Hung Luo, Markus Hecht, Benjamin Frey, Udo S Gaipl, Xue-Jun Li, Qi Zhao, Hu Ma, Jian-Guo Zhou
TCCIA: a comprehensive resource for exploring CircRNA in cancer immunotherapy. Journal for immunotherapy of cancer 12 (1) (2024)
Thomas Weissmann, Michael Rückert, Florian Putz, Anna-Jasmina Donaubauer, Markus Hecht, Sören Schnellhardt, Philipp Schubert, Johannes Roesch, Daniel Höfler, Oliver J Ott, Marlen Haderlein, Sebastian Lettmaier, Rainer Fietkau, Benjamin Frey, Udo S Gaipl, Lisa Deloch
Low-dose radiotherapy of osteoarthritis: from biological findings to clinical effects-challenges for future studies. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2023)
Mutaz A Abd Al-Razaq, Anna Isermann, Markus Hecht, Claudia E Rübe
Automated Image Analysis of Transmission Electron Micrographs: Nanoscale Evaluation of Radiation-Induced DNA Damage in the Context of Chromatin. Cells 12 (20) (2023)
Tim Fitz, Christopher Sörgel, Sandra Rutzner, Markus Hecht, Sandra Rutzner, Luitpold Valentin Distel
Baseline Quality of Life of Physical Function Is Highly Relevant for Overall Survival in Advanced Rectal Cancer. Healthcare (Basel, Switzerland) 10 (1) (2022)
Markus Hecht, Markus Eckstein, Sandra Rutzner, Jens von der Grün, Thomas Illmer, Gunther Klautke, Simon Laban, Matthias G Hautmann, Thomas B Brunner, Bálint Tamaskovics, Axel Hinke, Jian-Guo Zhou, Benjamin Frey, Anna-Jasmina Donaubauer, Ina Becker, Sabine Semrau, Arndt Hartmann, Panagiotis Balermpas, Wilfried Budach, Udo S Gaipl, Heinrich Iro, Antoniu-Oreste Gostian, Rainer Fietkau
Induction chemoimmunotherapy followed by CD8+ immune cell-based patient selection for chemotherapy-free radioimmunotherapy in locally advanced head and neck cancer. Journal for immunotherapy of cancer 10 (1) (2022)
Matthias Balk, Robin Rupp, Konstantinos Mantsopoulos, Matti Sievert, Magdalena Gostian, Moritz Allner, Philipp Grundtner, Markus Eckstein, Heinrich Iro, Markus Hecht, Antoniu-Oreste Gostian
Factors Influencing the Outcome of Head and Neck Cancer of Unknown Primary (HNCUP). Journal of clinical medicine 11 (10) (2022)
Julian Scheper, Laura S Hildebrand, Eva-Maria Faulhaber, Lisa Deloch, Udo S Gaipl, Julia Symank, Rainer Fietkau, Luitpold Valentin Distel, Markus Hecht, Tina Jost
Tumor-specific radiosensitizing effect of the ATM inhibitor AZD0156 in melanoma cells with low toxicity to healthy fibroblasts. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2022)
Sarina Katrin Müller, Marlen Haderlein, Sebastian Lettmaier, Abbas Agaimy, Florian Haller, Markus Hecht, Rainer Fietkau, Heinrich Iro, Konstantinos Mantsopoulos
Targeted Therapy, Chemotherapy, Immunotherapy and Novel Treatment Options for Different Subtypes of Salivary Gland Cancer. Journal of clinical medicine 11 (3) (2022)
Tina Jost, Barbara Schuster, Lucie Heinzerling, Thomas Weissmann, Rainer Fietkau, Luitpold Valentin Distel, Markus Hecht
Kinase inhibitors increase individual radiation sensitivity in normal cells of cancer patients. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 198 (9) (2022)
Michael Beck, Sabine Semrau, Marlen Haderlein, Antoniu-Oreste Gostian, Julius Hartwich, Sarina Katrin Müller, Annett Kallies, Carol-Immanuel Geppert, Miriam Schonath, Florian Putz, Udo S Gaipl, Benjamin Frey, Marc Saake, Heinrich Iro, Michael Uder, Arndt Hartmann, Torsten Kuwert, Rainer Fietkau, Markus Eckstein, Markus Hecht
Differences and Similarities in the Pattern of Early Metabolic and Morphologic Response after Induction Chemo-Immunotherapy versus Induction Chemotherapy Alone in Locally Advanced Squamous Cell Head and Neck Cancer. Cancers 14 (19) (2022)
Jian-Guo Zhou, Anna-Jasmina Donaubauer, Benjamin Frey, Ina Becker, Sandra Rutzner, Markus Eckstein, Roger Sun, Hu Ma, Philipp Schubert, Claudia Schweizer, Rainer Fietkau, Eric Deutsch, Udo S Gaipl, Markus Hecht
Prospective development and validation of a liquid immune profile-based signature (LIPS) to predict response of patients with recurrent/metastatic cancer to immune checkpoint inhibitors. Journal for immunotherapy of cancer 9 (2) (2022)
Thomas Weissmann, Sebastian Lettmaier, Anna-Jasmina Donaubauer, Christoph Bert, Manfred Schmidt, Friedrich Kruse, Oliver Ott, Markus Hecht, Rainer Fietkau, Benjamin Frey, Florian Putz
Low- vs. high-dose radiotherapy in Graves' ophthalmopathy: a retrospective comparison of long-term results. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 197 (10) (2021)
Markus Hecht, Dennis Hahn, Philipp Wolber, Matthias G Hautmann, Dietmar Reichert, Steffi Weniger, Claus Belka, Tobias Bergmann, Thomas Göhler, Manfred Welslau, Christina Große-Thie, Orlando Guntinas-Lichius, Jens von der Grün, Panagiotis Balermpas, Katrin Orlowski, Diethelm Messinger, Karsten G Stenzel, Sandra Rutzner
A Prospective Real-World Multi-Center Study to Evaluate Progression-Free and Overall Survival of Radiotherapy with Cetuximab and Platinum-Based Chemotherapy with Cetuximab in Locally Recurrent Head and Neck Cancer. Cancers 13 (14) (2021)
Markus Hecht, Antoniu Oreste Gostian, Markus Eckstein, Sandra Rutzner, Jens von der Grün, Thomas Illmer, Matthias G Hautmann, Gunther Klautke, Simon Laban, Thomas Brunner, Axel Hinke, Ina Becker, Benjamin Frey, Sabine Semrau, Carol I Geppert, Arndt Hartmann, Panagiotis Balermpas, Wilfried Budach, Udo S Gaipl, Heinrich Iro, Rainer Fietkau
Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8. Journal for immunotherapy of cancer 8 (2) (2021)
Eva-Maria Faulhaber, Tina Jost, Julia Symank, Julian Scheper, Felix Bürkel, Rainer Fietkau, Markus Hecht, Luitpold Valentin Distel
Kinase Inhibitors of DNA-PK, ATM and ATR in Combination with Ionizing Radiation Can Increase Tumor Cell Death in HNSCC Cells While Sparing Normal Tissue Cells. Genes 12 (6) (2021)
Stephanie Jonuscheit, Tina Jost, Fritzi Gajdošová, Maximilian Wrobel, Markus Hecht, Sandra Rutzner, Luitpold Valentin Distel
PARP Inhibitors Talazoparib and Niraparib Sensitize Melanoma Cells to Ionizing Radiation. Genes 12 (6) (2021)
Jian-Guo Zhou, Bo Liang, Jian-Guo Liu, Su-Han Jin, Si-Si He, Benjamin Frey, Ning Gu, Sandra Rutzner, Markus Hecht, Hu Ma, Udo S Gaipl
Identification of 15 lncRNAs Signature for Predicting Survival Benefit of Advanced Melanoma Patients Treated with Anti-PD-1 Monotherapy. Cells 10 (5) (2021)
Alexander Hofmann, Florian Putz, Maike Büttner-Herold, Markus Hecht, Rainer Fietkau, Luitpold Valentin Distel
Increase in non-professional phagocytosis during the progression of cell cycle. PloS one 16 (2) (2021)
Sebastian Wimmer, Lisa Deloch, Michael Hader, Anja Derer, Fridolin Grottker, Thomas Weissmann, Markus Hecht, Antoniu-Oreste Gostian, Sandra Rutzner, Benjamin Frey, Udo S Gaipl
Hypofractionated Radiotherapy Upregulates Several Immune Checkpoint Molecules in Head and Neck Squamous Cell Carcinoma Cells Independently of the HPV Status While ICOS-L Is Upregulated Only on HPV-Positive Cells. International journal of molecular sciences 22 (17) (2021)
Thomas Weissmann, Stefan Speer, Florian Putz, Sebastian Lettmaier, Philipp Schubert, Maya Shariff, Sabine Semrau, Antoniu-Oreste Gostian, Maximilian Traxdorf, Sarina Katrin Müller, Markus Eckstein, Matthias Hautmann, Jens von der Grün, Marlen Haderlein, Benjamin Frey, Udo S Gaipl, Christoph Bert, Heinrich Iro, Rainer Fietkau, Markus Hecht
Reduction of Elective Radiotherapy Treatment Volume in Definitive Treatment of Locally Advanced Head and Neck Cancer-Comparison of a Prospective Trial with a Revised Simulated Contouring Approach. Journal of clinical medicine 10 (20) (2021)
Roger Sun, Nora Sundahl, Markus Hecht, Florian Putz, Andrea Lancia, Angela Rouyar, Marina Milic, Alexandre Carré, Enzo Battistella, Emilie Alvarez Andres, Stéphane Niyoteka, Edouard Romano, Guillaume Louvel, Jérôme Durand-Labrunie, Sophie Bockel, Rastilav Bahleda, Charlotte Robert, Celine Boutros, Maria Vakalopoulou, Nikos Paragios, Benjamin Frey, Jean-Charles Soria, Christophe Massard, Charles Ferté, Rainer Fietkau, Piet Ost, Udo S Gaipl, Eric Deutsch
Radiomics to predict outcomes and abscopal response of patients with cancer treated with immunotherapy combined with radiotherapy using a validated signature of CD8 cells. Journal for immunotherapy of cancer 8 (2) (2021)
Barbara Schuster, Markus Hecht, Manfred Schmidt, Marlen Haderlein, Tina Jost, Maike Büttner-Herold, Klaus Weber, Axel Denz, Robert Grützmann, Arndt Hartmann, Werner Langsteger, Rainer Fietkau, Luitpold Valentin Distel
Influence of Gender on Radiosensitivity during Radiochemotherapy of Advanced Rectal Cancer. Cancers 14 (1) (2021)
Sabine Semrau, Antoniu-Oreste Gostian, Maximilian Traxdorf, Markus Eckstein, Sandra Rutzner, Jens von der Grün, Thomas Illmer, Matthias Hautmann, Gunther Klautke, Simon Laban, Thomas Brunner, Bálint Tamaskovics, Benjamin Frey, Jian-Guo Zhou, Carol-Immanuel Geppert, Arndt Hartmann, Panagiotis Balermpas, Wilfried Budach, Udo S Gaipl, Heinrich Iro, Rainer Fietkau, Markus Hecht
Implementation of Double Immune Checkpoint Blockade Increases Response Rate to Induction Chemotherapy in Head and Neck Cancer. Cancers 13 (8) (2021)
Markus Hecht, Dennis Hahn, Philipp Wolber, Matthias G Hautmann, Dietmar Reichert, Steffi Weniger, Claus Belka, Tobias Bergmann, Thomas Göhler, Manfred Welslau, Christina Große-Thie, Orlando Guntinas-Lichius, Jens von der Grün, Panagiotis Balermpas, Katrin Orlowski, Diethelm Messinger, Karsten G Stenzel, Rainer Fietkau
Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer. BMC cancer 20 (1) (2020)
Felix Bürkel, Tina Jost, Markus Hecht, Lucie Heinzerling, Rainer Fietkau, Luitpold Valentin Distel
Dual mTOR/DNA-PK Inhibitor CC-115 Induces Cell Death in Melanoma Cells and Has Radiosensitizing Potential. International journal of molecular sciences 21 (23) (2020)
Maike Jörling, Sandra Rutzner, Markus Hecht, Rainer Fietkau, Luitpold Valentin Distel
Deterioration of Health-Related Quality of Life Scores under Treatment Predicts Longer Survival. BioMed research international 2020 (2020)
Fabian Frank, Markus Hecht, Florian Loy, Sandra Rutzner, Rainer Fietkau, Luitpold Valentin Distel
Differences in and Prognostic Value of Quality of Life Data in Rectal Cancer Patients with and without Distant Metastases. Healthcare (Basel, Switzerland) 9 (1) (2020)
Clara Dobler, Tina Jost, Markus Hecht, Rainer Fietkau, Luitpold Valentin Distel
Senescence Induction by Combined Ionizing Radiation and DNA Damage Response Inhibitors in Head and Neck Squamous Cell Carcinoma Cells. Cells 9 (9) (2020)
Sebastian Winkler, Philipp Hoppe, Marlen Haderlein, Markus Hecht, Rainer Fietkau, Luitpold Valentin Distel
Ex Vivo Apoptosis in CD8+ Lymphocytes Predicts Rectal Cancer Patient Outcome. Gastroenterology research and practice 2016 (2016)